Proteome Sciences Eyes $8.3M Raise | GenomeWeb

NEW YORK (GenomeWeb News) – Proteome Sciences today announced a conditional placement of nearly 17.9 million new ordinary shares in order to raise £5 million ($8.3 million).

The UK-based firm said it has conditionally placed the shares of ₤.01 each to raise the funds with new and existing investors at ₤.28 per share. Proteome Sciences Chief Executive Christopher Pearce has subscribed for about 3.6 million shares at the placing price, and following the transaction he will hold 35.1 million, or a little more than 16 percent, of the firm's enlarged share capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.